Cigarettes with ultralow nicotine levels are now being called the game-changer in the fight against smoking. If you are having trouble in quitting smoking, then, it is for you, that soon the Biden White House is expected to formally propose a plan that will order cigarette nicotine levels to be reduced, reports The Washington Post. For now though, it has been a failure, as these cigarettes, also known as VLN cigarettes that stands for very low nicotine are only available in 5,100 stores in 26 states. This is a very small fraction of the overall market for cigarettes. The company that makes it, 22nd Century, is struggling not because of the low supply, but also from the advocates who have long believed slashing nicotine levels altogether.
Nicotine is a chemical that is produced naturally from tobacco that makes the cigarette and also keeps people hooked. While it is believed that it makes people alert, and get the "hit" to keep them going, it exposes the users to harmful substances, carcinogens, and increases the risk of heart disease, lung cancer, and other illness.
Ultralow-nicotine cigarettes, like the VLN brand, contain about 95% less nicotine than the regular cigarettes. The idea is quite simple: without the addictive grip of nicotine, smokers will find it easier to quit. Research too has shown some promise. For instance, the studies funded by the National Institute on Drug Abuse revealed that very low nicotine cigarettes reduced addiction potential significantly without having users to increase their smoking frequency. However, the problem is, why would anyone choose for a low-nicotine that does not make them feel the same way, when the high-nicotine cigarette is right next to it, making them feel the same way, with the same alertness, sold at the same price.
“It’s very hard to imagine someone actively choosing to continue to use a low-nicotine product for the same price when a high-nicotine product is right next to it,” said Eric Donny, a Wake Forest University School of Medicine nicotine researcher.
No wonder, the experiment with low nicotine product by Philip Morris' Next cigarettes in the 1980s and Vector Tobacco's Quest brand in the early 2000s, flopped.
The Food and Drug Administration (FDA) has supported the development of such products, even allowing VLN cigarettes to be marketed as lower-risk options. However, these products remain a niche market, available in only a fraction of U.S. stores.
Recently, the Biden administration has considered a bold step—mandating a dramatic reduction in nicotine levels for all cigarettes sold in the United States. Supporters believe this move could save millions of lives, while critics, including tobacco companies, warn of potential unintended consequences.
Resistance from Big Tobacco Companies: They could argue that slashing nicotine levels could backfire. Their claim is, smokers will turn to black markets or smoke more to satisfy their cravings, which may lead to greater exposure to harmful substances.
Consumer Reluctance: History is proof to the instances of smokers being hesitant to embrace the low-nicotine products.
Political Hurdle: It may face political roadblocks, as under the Trump administration, plans to cut nicotine were shelved.
Advocates believe that ultralow-nicotine cigarettes could be a game-changer, comparing them to decaf coffee or non-alcoholic beer—products that reduce harm while offering a similar experience.
Some experts warn that a black market for traditional cigarettes could undermine these efforts. They also stress the need for safer alternatives, such as vaping products, to support smokers transitioning away from traditional cigarettes.
Credit: Canva/Eli Lilly
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has authorized Eli Lilly’s orforglipron, marketed as Foundayo, for weight management and type 2 diabetes.
With the approval, the UK has become the first country in Europe to authorize Lilly’s once-daily GLP-1 tablet. It is also the second oral GLP-1 weight-loss medicine authorized in the UK after Novo Nordisk’s Wegovy.
“As with all GLP-1 receptor agonists, this is a prescription-only medication, and the MHRA will keep the safety and effectiveness of orforglipron under close review,” said Julian Beach, MHRA Executive Director of Healthcare Quality and Access.
Orforglipron is a prescription-only pill and is authorised for weight loss and weight maintenance in adults with:
Unlike injectable GLP-1 medicines such as Wegovy and Mounjaro, Foundayo is taken as a once-daily tablet. It can be taken at any time of day, with no restrictions on food or water.
Treatment starts at 0.8 mg and is gradually increased through 2.5 mg, 5.5 mg, 9 mg, 14.5 mg and 17.2 mg, with at least one month at each dose level. Patients should follow the dosing instructions provided with the medicine.
Although Foundayo has been authorized for use in the UK, it is not currently available through the NHS. The NHS availability will depend on established processes, including assessment by the National Institute for Health and Care Excellence (NICE).
The MHRA urged people to buy the prescription only GLP-1 medicines from a registered pharmacy, with a prescription from a doctor. Buying GLP-1 medicines from unregulated sellers carries serious health risks.
Orforglipron is Eli Lilly’s first oral GLP-1 medicine for weight management, marketed as Foundayo. It was approved by the US Food and Drug Administration (FDA) in April this year.
The medicine is a GLP-1 receptor agonist that mimics the action of glucagon-like peptide-1, a hormone involved in appetite and blood sugar regulation.
By activating GLP-1 receptors, orforglipron helps reduce hunger and food cravings and increases feelings of fullness. Along with diet and lifestyle changes, this can support weight loss.
In people with type 2 diabetes, it also helps lower blood glucose levels. Unlike some oral GLP-1 medicines, orforglipron does not require patients to take it on an empty stomach or avoid food and water around the time of dosing.
A recent clinical trial led by Weill Cornell Medicine and NewYork-Presbyterian showed that Foundayo may be help prevent rebound weight gain caused by GLP-1 weight-loss drugs such as Wegovy and Mounjaro.
The ATTAIN-MAINTAIN trial included people who had previously taken tirzepatide or semaglutide and whose weight loss had plateaued.
Foundayo is not approved for use in children. Its safety information also includes a warning about the potential risk of thyroid tumours, including thyroid cancer.
Patients should seek medical advice if they develop symptoms such as:
Credit: Instagram
Amid speculation about a potential 2028 US presidential run, Congresswoman Alexandria Ocasio-Cortez has revealed that she plans to freeze her eggs.
The 36-year-old New York Democrat shared her decision in a series of Instagram Stories, including footage of herself administering fertility medication.
“This is a choice that I am making to feel more in control of my life,” Ocasio-Cortez said.
Ocasio-Cortez said she had been saving for the procedure for a long time and noted that women often lack information about fertility and their reproductive health.
She also spoke about balancing fertility treatment with her work as a congresswoman, saying she would take her medication injections in a dressing room before a scheduled ABC interview.
“I want you all to see that,” she said, adding that women can balance fertility treatment with their professional lives. Ocasio-Cortez also showed some of the medicines and supplies used during the process, including syringes and alcohol wipes. Egg-freezing treatment typically involves hormone injections over about 10 days or longer.
She joked about the process before administering an injection herself. Afterward, she said: “That wasn’t so bad!”
During an interview with ABC News, Ocasio-Cortez said she had not “ruled out the possibility” of running for president. She also said she wanted to normalize conversations about fertility treatment, particularly for working women.
“In this political environment where this administration is denying reproductive care to women across the country, from abortion rights to the ability to carry out a healthy pregnancy, I think it’s important for us as leaders to have these conversations and share these processes,” she said.
Egg freezing, medically known as oocyte cryopreservation, allows women to preserve eggs at a younger reproductive age for potential use in the future.
It does not guarantee a future pregnancy but can provide an additional reproductive option for women who want to delay childbearing for personal, social or medical reasons.
Planned egg freezing may be considered after appropriate counselling and fertility assessment, particularly when undertaken at a younger age.
Dr. Tarang Yadav, Senior Consultant – IVF, Obstetrics and Gynecology, ShardaCare–Healthcity, told HealthandMe that fertility preservation may benefit women who:
“In such situations, fertility preservation can provide psychological reassurance and reproductive flexibility before ovarian function declines further,” Dr. Tarang said.
Egg-freezing outcomes are generally better when eggs are frozen at a younger age, particularly before 35. Younger eggs tend to have better quality and chromosomal competence, which may improve the chances of successful IVF in the future.
Dr. Tarang stressed the importance of early fertility counselling and ovarian reserve assessment. Tests such as Anti-Müllerian Hormone (AMH), ultrasound-based antral follicle count (AFC) and an overall reproductive evaluation can help determine whether egg freezing is appropriate.
Credit: iStock
After recalling lettuce that may have been linked to a severe nationwide Cyclospora outbreak in the US, Taylor Farms has now recalled 20 more products, including salsa and guacamole, over concerns about possible Salmonella contamination.
Taylor Farms also said on social media that none of its Taylor Farms-branded salad kits are associated with the outbreak. Most of the recalled lettuce was sold in large bags to food-service operations, including restaurants, with many products containing romaine lettuce.
In a statement on August 9, Taylor Farms said the latest recall is tied to fresh jalapeños supplied by Coast Citrus Distributors. A grower in Sinaloa, Mexico, that supplies Coast Citrus was identified as a potential source of the Salmonella outbreak.
“Taylor Fresh Foods is no longer sourcing products from this farmer and will be filling orders from alternative suppliers,” the company said on its website.
Also read: Alexandria Ocasio-Cortez Plans To Freeze Eggs As She Eyes 2028 US Presidential Run
The recalled products were sold in several states, including Texas, and distributed to major retailers such as Target, Walmart and Whole Foods.
Taylor Farms products were also recalled from Target, Trader Joe’s and Scarborough, Maine-based supermarket chain Hannaford across about 20 states.
Walmart said it had removed the impacted products from its stores and implemented a sales block at its registers and online. Kroger, Target, Whole Foods, Trader Joe’s and Hannaford-parent Ahold Delhaize did not immediately respond to a Reuters request for comment.
The CDC and FDA said earlier this week that they were investigating a Salmonella outbreak that had sickened 345 people across 27 states and led to 36 hospitalizations.
The US investigation identified restaurants including Chipotle Mexican Grill and Qdoba as having received jalapeños imported by Coast Citrus Distributors, Reuters reported.
Both restaurants stopped using the jalapeños, while Coast Citrus recalled the remaining product and notified customers.
The US Department of Agriculture (USDA) has also issued a new public health alert for 18 meat and poultry products containing recalled jalapeño peppers potentially contaminated with Salmonella.
The products were made using jalapeños that had already been recalled by the FDA. Many of the affected products are sold under brands including Taylor Farms, Walmart’s Marketside and H-E-B. The products have expiry dates extending through August 15.
The USDA’s Food Safety and Inspection Service (FSIS) said the issue came to light after the FDA notified the agency that several meat and poultry establishments had received the recalled jalapeños as an ingredient.
The agency warned that some of the products may still be sitting in consumers’ refrigerators or freezers and advised people not to eat them. Retailers have also been told not to sell the affected products.
Young children, older adults and people with weakened immune systems are at greater risk of developing severe illness.
Contaminated food may look, smell and taste completely normal, meaning consumers cannot rely on appearance or taste to determine whether food is safe.
Consumers who have purchased products covered by the USDA alert should not eat them. They should discard them safely or return them to the place of purchase.
Anyone who develops symptoms after eating a potentially contaminated product should contact a healthcare provider and disclose the possible Salmonella exposure.
© 2024 Bennett, Coleman & Company Limited